Caris Life Sciences Q2 2026 Revenue Up 45%
August 05, 2026
1 min read
8 views
cybersecurity
news
newsapi
Caris Life Sciences reported Q2 2026 revenue growth of 45%, driven by strong molecular profiling services, and raised its full-year revenue guidance.
Was this article helpful?
0 found this helpful